Covid-19 vaccine: Germany says patent protection ‘must remain’

A bold US bid to waive patents on much-needed coronavirus vaccines was strongly opposed by Germany on Thursday, threatening to derail the proposal that requires the consensus of World Trade Organization members to pass.

Pfizer CEO Albert Bourla meanwhile told AFP his company was “not at all” in favor of the measure, insisting intellectual property is not the main roadblock to more production and that building new plants would be counterproductive.

Covid-19 vaccine: Germany says patent protection ‘must remain’

Explained: Intellectual property waiver for Covid-19 vaccines

US backs Covid-19 vaccine IP waiver; global pharma companies irked

Covid-19: Why IPR waiver may not end vaccine apartheid so soon

Single dose Covid vaccine Sputnik Light gets approval in Russia


Leave a Reply

Your email address will not be published. Required fields are marked *